OBJECTIVES: We examined racial/ethnic disparities in HIV infection among injection drug users (IDUs) before and after implementation of large-scale syringe exchange programs in New York City. METHODS: Participants were recruited from IDUs entering the Beth Israel drug detoxification program in New York City. Participants (n = 1203) recruited from 1990 through 1994, prior to large-scale syringe exchange programs (pre-exchange), were compared with 1109 participants who began injecting in 1995 or later and were interviewed in 1995 through 2008 (post-exchange). RESULTS: There were large differences in HIV prevalence among pre-exchange vs post-exchange participants (African Americans, 57% vs 15%; Hispanics, 53% vs 5%; Whites, 27% vs 3%). Pre- and post-exchange relative disparities of HIV prevalence were similar for African Americans vs Whites (adjusted odds ratio [AOR] = 3.46, 95% confidence interval [CI] = 2.41, 4.96 and AOR = 4.02, 95% CI = 1.67, 9.69, respectively) and Hispanics vs Whites (AOR = 1.76, 95% CI = 1.49, 2.09 and AOR = 1.49, 95% CI = 1.02, 2.17). Racial/ethnic group differences in risk behavior did not explain differences in HIV prevalence. CONCLUSIONS: New interventions are needed to address continuing disparities in HIV infection among IDUs, but self-reported risk behaviors by themselves may not be adequate outcome measures for evaluating interventions to reduce racial/ethnic disparities in HIV infection.
OBJECTIVES: We examined racial/ethnic disparities in HIV infection among injection drug users (IDUs) before and after implementation of large-scale syringe exchange programs in New York City. METHODS:Participants were recruited from IDUs entering the Beth Israel drug detoxification program in New York City. Participants (n = 1203) recruited from 1990 through 1994, prior to large-scale syringe exchange programs (pre-exchange), were compared with 1109 participants who began injecting in 1995 or later and were interviewed in 1995 through 2008 (post-exchange). RESULTS: There were large differences in HIV prevalence among pre-exchange vs post-exchange participants (African Americans, 57% vs 15%; Hispanics, 53% vs 5%; Whites, 27% vs 3%). Pre- and post-exchange relative disparities of HIV prevalence were similar for African Americans vs Whites (adjusted odds ratio [AOR] = 3.46, 95% confidence interval [CI] = 2.41, 4.96 and AOR = 4.02, 95% CI = 1.67, 9.69, respectively) and Hispanics vs Whites (AOR = 1.76, 95% CI = 1.49, 2.09 and AOR = 1.49, 95% CI = 1.02, 2.17). Racial/ethnic group differences in risk behavior did not explain differences in HIV prevalence. CONCLUSIONS: New interventions are needed to address continuing disparities in HIV infection among IDUs, but self-reported risk behaviors by themselves may not be adequate outcome measures for evaluating interventions to reduce racial/ethnic disparities in HIV infection.
Authors: D C Des Jarlais; T Perlis; S R Friedman; S Deren; T Chapman; J L Sotheran; S Tortu; M Beardsley; D Paone; L V Torian; S T Beatrice; E DeBernardo; E Monterroso; M Marmor Journal: Am J Public Health Date: 1998-12 Impact factor: 9.308
Authors: D C Des Jarlais; S R Friedman; D M Novick; J L Sotheran; P Thomas; S R Yancovitz; D Mildvan; J Weber; M J Kreek; R Maslansky Journal: JAMA Date: 1989-02-17 Impact factor: 56.272
Authors: Claire E Ryan; Julian H Elliott; Tracey Middleton; Anne M Mijch; Alan C Street; Margaret Hellard; Nick Crofts; Suzanne M Crowe; Robert B Oelrichs Journal: AIDS Res Hum Retroviruses Date: 2004-12 Impact factor: 2.205
Authors: Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Holly Hagan; Judith Milliken; Naomi Braine; Stanley Yancovitz; Donna Mildvan; David C Perlman; Carey Maslow; Samuel R Friedman Journal: J Acquir Immune Defic Syndr Date: 2004-02-01 Impact factor: 3.731
Authors: Kevin J P Craib; Patricia M Spittal; Evan Wood; Nancy Laliberte; Robert S Hogg; Kathy Li; Katherine Heath; Mark W Tyndall; Michael V O'Shaughnessy; Martin T Schechter Journal: CMAJ Date: 2003-01-07 Impact factor: 8.262
Authors: E E Schoenbaum; D Hartel; P A Selwyn; R S Klein; K Davenny; M Rogers; C Feiner; G Friedland Journal: N Engl J Med Date: 1989-09-28 Impact factor: 91.245
Authors: Don C Des Jarlais; Courtney McKnight; Kamyar Arasteh; Jonathan Feelemyer; David C Perlman; Holly Hagan; Emily F Dauria; Hannah L F Cooper Journal: Subst Use Misuse Date: 2014-02-06 Impact factor: 2.164
Authors: Patrick A Wilson; Jose Nanin; Silvia Amesty; Scyatta Wallace; Emily M Cherenack; Robert Fullilove Journal: J Urban Health Date: 2014-10 Impact factor: 3.671
Authors: Don C Des Jarlais; Kamyar Arasteh; Jonathan Feelemyer; Courtney McKnight; Susan Tross; David C Perlman; Aimee N C Campbell; Holly Hagan; Hannah L F Cooper Journal: Sex Transm Dis Date: 2017-02 Impact factor: 2.830
Authors: Ashly E Jordan; Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Denis Nash; David C Perlman Journal: Drug Alcohol Depend Date: 2015-04-13 Impact factor: 4.492
Authors: Kora DeBeck; Tessa Cheng; Julio S Montaner; Chris Beyrer; Richard Elliott; Susan Sherman; Evan Wood; Stefan Baral Journal: Lancet HIV Date: 2017-05-14 Impact factor: 12.767
Authors: Don C Des Jarlais; Courtney McKnight; Kamyar Arasteh; Jonathan Feelemyer; David Perlman; Holly Hagan; Hannah L F Cooper Journal: J Urban Health Date: 2014-06 Impact factor: 3.671